Narcolepsy

Clinical trials recruiting in Australia for Narcolepsy, as the public registries list them.

Also called: Gelineau syndrome; Narcoleptic syndrome

Sources: ClinicalTrials.gov, MedlinePlus Checked: 15 October 2026 Not medical advice

At a glance

6 trials recruiting in Australia

3 states or territories with a listed site

0 started recruiting in the last 30 days

28 trials recruiting overseas

15 October 2026 date last checked

Where the trials are

Listed sites in each state and territory. Choose one to show only the trials with a site there, and choose it again to show them all.

1 listed site on this page does not say which state it is in, so the counts above are lower than the real number of sites in some states. The trials themselves are all listed below.

Trials for Narcolepsy

6 of 6 trials shown.

This Australian count is likely to be on the low side. It counts the trials this site files under this condition; the registry’s own search is broader and also returns closely related conditions, some of which have their own page here. If you are searching widely, check the registry as well — every trial below links to its own record.

  • Recruiting Not a phased study

    Study for people with Narcolepsy

    Where
    • Online Patient Enrollment System, Sydney — Recruiting
    Who can join Age child, adult, older adult. Sex Anyone, regardless of sex. Healthy volunteers Not accepted.
    Sponsor Sanford Health
    Timeline
    Started 1 July 2010 Today 16 October 2026 Estimated completion 1 December 2100

    NCT01793168 · Checked 11 October 2026

  • Recruiting Phase 3

    Phase 3 study for people with Narcolepsy

    Where
    • Woolcock Institute of Medical Research, Glebe (NSW) — Recruiting
    Who can join Age 16 Years to 70 Years. Sex Anyone, regardless of sex. Healthy volunteers Not accepted.
    Sponsor Takeda
    Timeline
    Started 5 April 2023 Today 16 October 2026 Estimated completion 28 February 2028

    NCT05816382 · Checked 11 October 2026

  • Recruiting Phase 3

    Phase 3 study for people with Narcolepsy

    Where
    • Alkermes Investigational Site, Sydney (NSW) — Recruiting
    • Alkermes Investigational Site, Bedford Park (SA) — Recruiting
    • Alkermes Investigational Site, Clayton (VIC) — Recruiting
    Who can join Age 18 Years to 70 Years. Sex Anyone, regardless of sex. Healthy volunteers Not accepted.
    Sponsor Alkermes, Inc.
    Timeline
    Started 27 January 2025 Today 16 October 2026 Estimated completion 1 June 2030

    NCT06767683 · Checked 15 October 2026

  • Recruiting Not a phased study

    Study for people with Narcolepsy

    Where
    • Woolcock Institute of Medical Research, Macquarie Park (NSW) — Recruiting
    Who can join Age 18 Years and over. Sex Anyone, regardless of sex. Healthy volunteers Not accepted.
    Sponsor University of Sydney
    Timeline
    Started 23 June 2025 Today 16 October 2026 Estimated completion 1 June 2026

    Past estimated completion. The registry still lists this trial as open, and the date it gave for finishing has been and gone. Confirm with the official record before you act on it.

    NCT07006233 · Checked 11 October 2026

  • Recruiting Phase 3

    Phase 3 study for people with Narcolepsy

    Where
    • Alkermes Investigational Site, Macquarie Park (NSW) — Recruiting
    Who can join Age 18 Years to 70 Years. Sex Anyone, regardless of sex. Healthy volunteers Not accepted.
    Sponsor Alkermes, Inc.
    Timeline
    Started 6 April 2026 Today 16 October 2026 Estimated completion 1 May 2027

    NCT07455383 · Checked 14 October 2026

  • Recruiting Phase 2

    Phase 2 study for people with Narcolepsy

    Where

    No Australian site on this record is listed as recruiting right now, even though the trial itself is open. Check with the site or the official record before travelling.

    • Takeda Site 2, Macquarie Park (NSW) — Not yet recruiting
    Who can join Age 18 Years to 70 Years. Sex Anyone, regardless of sex. Healthy volunteers Not accepted.
    Sponsor Takeda
    Timeline
    Started 4 June 2026 Today 16 October 2026 Estimated completion 28 November 2027

    NCT07633301 · Checked 11 October 2026

voxsanity.com.au · trial list from public registries · page built 16 October 2026 · not medical advice

Trials not shown here

Some Australian trials are registered only on the Australian New Zealand Clinical Trials Registry and are not shown here. Search them at Australian Clinical Trials.

Trials overseas

28 trials for this condition are open to new participants outside Australia, as ClinicalTrials.gov listed them on 11 October 2026. Voxsanity does not publish a page for any of them; the searches below reach them at the registry.

These overseas counts are likely too high. They come from the registry’s own search, which expands a condition name to related conditions, so some of the trials counted are for a different disease in the same family.

About Narcolepsy

The text below is reproduced exactly as its source published it. It has not been edited, shortened or rewritten.

Narcolepsy is a chronic sleep disorder that disrupts the normal sleep-wake cycle. Although this condition can appear at any age, it most often begins in adolescence. Narcolepsy is characterized by excessive daytime sleepiness. Affected individuals feel tired during the day, and several times a day they may experience an overwhelming urge to sleep. "Sleep attacks" can occur at unusual times, such as during a meal or in the middle of a conversation. They last from a few seconds to a few minutes and often lead to a longer nap, after which affected individuals wake up feeling refreshed. Another common feature of narcolepsy is cataplexy, which is a sudden loss of muscle tone in response to strong emotion (such as laughing, surprise, or anger). These episodes of muscle weakness can cause an affected person to slump over or fall, which occasionally leads to injury. Episodes of cataplexy usually last just a few seconds, and they may occur from several times a day to a few times a year. Most people diagnosed with narcolepsy also have cataplexy. However, some do not, which has led researchers to distinguish two major forms of the condition: narcolepsy with cataplexy and narcolepsy without cataplexy. Narcolepsy also affects nighttime sleep. Most affected individuals have trouble sleeping for more than a few hours at night. They often experience vivid hallucinations while falling asleep (hypnogogic hallucinations) or while waking up (hypnopompic hallucinations). Affected individuals often have realistic and distressing dreams, and they may act out their dreams by moving excessively or talking in their sleep. Many people with narcolepsy also experience sleep paralysis, which is an inability to move or speak for a short period while falling asleep or awakening. The combination of hallucinations, vivid dreams, and sleep paralysis is often frightening and unpleasant for affected individuals. Some people with narcolepsy have all of the major features of the disorder, while others have only one or two. Most of the signs and symptoms persist throughout life, although episodes of cataplexy may become less frequent with age and treatment.

US source; availability in Australia may differ.

Source: MedlinePlus Genetics (medlineplus.gov), public domain (U.S. National Library of Medicine). Read the full source.

Sources and dates

  • ClinicalTrials.gov – trial records, statuses and site lists
  • MedlinePlus – the About text above, reproduced exactly
  • ClinicalTrials.gov processing date: 9 October 2026.
  • This page last checked by Voxsanity: 15 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Tell us which conditions matter to you

We use requests to help decide what to add next. Telling us about a condition is not a promise that we will add it, and we cannot say when any condition might appear.